Filomena Silva

747 total citations
20 papers, 563 citations indexed

About

Filomena Silva is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, Filomena Silva has authored 20 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Neurology and 3 papers in Pharmacology. Recurrent topics in Filomena Silva's work include Amyotrophic Lateral Sclerosis Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Retinoids in leukemia and cellular processes (5 papers). Filomena Silva is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (6 papers), Mitochondrial Function and Pathology (5 papers) and Retinoids in leukemia and cellular processes (5 papers). Filomena Silva collaborates with scholars based in Portugal, United States and Russia. Filomena Silva's co-authors include Paulo J. Oliveira, Maria F. Duarte, Teresa Cunha‐Oliveira, Omidreza Firuzi, Luciano Saso, Rui F. Simões, Albert A. Rizvanov, José B.A. Custódio, Mariana P.C. Ribeiro and Susana P. Pereira and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Molecules and European Journal of Pharmacology.

In The Last Decade

Filomena Silva

20 papers receiving 557 citations

Peers

Filomena Silva
Sarah L. Miles United States
Grit Sandig Germany
Philip Y. Lam Hong Kong
Qian Yu China
Nathan I. Lopez United States
Filomena Silva
Citations per year, relative to Filomena Silva Filomena Silva (= 1×) peers Silvia Grottelli

Countries citing papers authored by Filomena Silva

Since Specialization
Citations

This map shows the geographic impact of Filomena Silva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Filomena Silva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Filomena Silva more than expected).

Fields of papers citing papers by Filomena Silva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Filomena Silva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Filomena Silva. The network helps show where Filomena Silva may publish in the future.

Co-authorship network of co-authors of Filomena Silva

This figure shows the co-authorship network connecting the top 25 collaborators of Filomena Silva. A scholar is included among the top collaborators of Filomena Silva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Filomena Silva. Filomena Silva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cunha‐Oliveira, Teresa, et al.. (2024). Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis. Cells. 13(3). 248–248. 17 indexed citations
2.
Silva, Filomena, et al.. (2023). Amyotrophic Lateral Sclerosis: When Nerve Cells Run Out of Power. Frontiers for Young Minds. 11. 1 indexed citations
3.
Cunha‐Oliveira, Teresa, Vilma A. Sardão, Elisabete Ferreiro, et al.. (2022). Integrative Profiling of Amyotrophic Lateral Sclerosis Lymphoblasts Identifies Unique Metabolic and Mitochondrial Disease Fingerprints. Molecular Neurobiology. 59(10). 6373–6396. 3 indexed citations
4.
Soares, Pedro, et al.. (2022). Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities. Ageing Research Reviews. 83. 101790–101790. 36 indexed citations
5.
Cunha‐Oliveira, Teresa, Inês Baldeiras, Ricardo Marques, et al.. (2022). Redox profiles of amyotrophic lateral sclerosis lymphoblasts with or without known SOD1 mutations. European Journal of Clinical Investigation. 52(9). e13798–e13798. 4 indexed citations
6.
Fernandes, Carlos, Fernando Cagide, Pedro Soares, et al.. (2022). Targeting Hydroxybenzoic Acids to Mitochondria as a Strategy to Delay Skin Ageing: An In Vitro Approach. Molecules. 27(19). 6183–6183. 7 indexed citations
7.
Fernandes, Carlos, Sofia Benfeito, Pedro Soares, et al.. (2021). Cytotoxicity and Mitochondrial Effects of Phenolic and Quinone-Based Mitochondria-Targeted and Untargeted Antioxidants on Human Neuronal and Hepatic Cell Lines: A Comparative Analysis. Biomolecules. 11(11). 1605–1605. 12 indexed citations
8.
Cunha‐Oliveira, Teresa, et al.. (2020). Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention. Oxidative Medicine and Cellular Longevity. 2020. 1–29. 131 indexed citations
9.
Coelho, Ana R., Cláudia M. Deus, Cláudia V. Pereira, et al.. (2017). Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1863(11). 2904–2923. 68 indexed citations
10.
Silva, Filomena, et al.. (2016). Targeting Mitochondria in Cardiovascular Diseases. Current Pharmaceutical Design. 22(37). 5698–5717. 28 indexed citations
11.
Silva, Filomena, et al.. (2016). Determination of Metabolic Viability and Cell Mass Using a Tandem Resazurin/Sulforhodamine B Assay. Current Protocols in Toxicology. 68(1). 2.24.1–2.24.15. 45 indexed citations
12.
Silva, Filomena, Paulo J. Oliveira, & Maria F. Duarte. (2016). Oleanolic, Ursolic, and Betulinic Acids as Food Supplements or Pharmaceutical Agents for Type 2 Diabetes: Promise or Illusion?. Journal of Agricultural and Food Chemistry. 64(15). 2991–3008. 126 indexed citations
13.
Silva, Filomena, Hugo Oliveira, João Carlos Fernandes, et al.. (2013). Cytotoxic and genotoxic effects of acitretin, alone or in combination with psoralen–ultraviolet A or narrow-band ultraviolet B-therapy in psoriatic patients. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 753(1). 42–47. 8 indexed citations
14.
Silva, Filomena, Hugo Oliveira, João Carlos Fernandes, et al.. (2013). The in vitro and in vivo genotoxicity of isotretinoin assessed by cytokinesis blocked micronucleus assay and comet assay. Toxicology in Vitro. 27(2). 900–907. 3 indexed citations
16.
Silva, Filomena, Mariana P.C. Ribeiro, Maria S. Santos, et al.. (2013). The antiestrogen 4-hydroxytamoxifen protects against isotretinoin-induced permeability transition and bioenergetic dysfunction of liver mitochondria: comparison with tamoxifen. Journal of Bioenergetics and Biomembranes. 45(4). 383–396. 3 indexed citations
17.
Silva, Filomena, Mariana P.C. Ribeiro, Maria S. Santos, et al.. (2013). Acitretin affects bioenergetics of liver mitochondria and promotes mitochondrial permeability transition: Potential mechanisms of hepatotoxicity. Toxicology. 306. 93–100. 24 indexed citations
18.
Ribeiro, Mariana P.C., Filomena Silva, Armanda E. Santos, Maria S. Santos, & José B.A. Custódio. (2012). The antiestrogen endoxifen protects rat liver mitochondria from permeability transition pore opening and oxidative stress at concentrations that do not affect the phosphorylation efficiency. Toxicology and Applied Pharmacology. 267(1). 104–112. 5 indexed citations
19.
Custódio, José B.A., et al.. (2011). The essential oils component p-cymene induces proton leak through Fo-ATP synthase and uncoupling of mitochondrial respiration. Journal of Experimental Pharmacology. 3. 69–69. 23 indexed citations
20.
Almeida, Maria Ângela Ornelas de, et al.. (2010). Efeito inibitório in vitro de extrato vegetal de Allium sativum sobre Aspergillus niger Tiegh. Revista Brasileira de Plantas Medicinais. 12(1). 13–17. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026